TrialLancet (London, England)2016

Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.

Jeffrey H Lawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.